Join
Live feed
·
PRReleasevia Quantisnow
Aclarion Inc. logo

Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data

ByQuantisnow·Wall Street's wire, on your screen.
ACON· Aclarion Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACON (Aclarion Inc.) and more on Quantisnow.